1. Home
  2. Analysis
  3. Oxycodone-and-acetaminophen
  4. Letairis

Oxycodone and acetaminophen and Letairis drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 26 people who take Oxycodone and acetaminophen and Letairis. Common interactions include chest pain among females, and death among males.

The phase IV clinical study analyzes what interactions people who take Oxycodone and acetaminophen and Letairis have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 26, 2023

26 people who take Oxycodone and acetaminophen and Letairis together, and have interactions are studied.

What is Oxycodone and acetaminophen?

Oxycodone and acetaminophen has active ingredients of acetaminophen; oxycodone hydrochloride. It is used in pain. Currently, eHealthMe is studying from 13,280 Oxycodone and acetaminophen users.

What is Letairis?

Letairis has active ingredients of ambrisentan. It is used in pulmonary hypertension. Currently, eHealthMe is studying from 93,429 Letairis users.

Number of Oxycodone and acetaminophen and Letairis reports submitted per year:

Oxycodone and acetaminophen and Letairis drug interactions.

Common Oxycodone And Acetaminophen and Letairis drug interactions by gender *:

female:

  1. Chest pain
  2. Drug ineffective
  3. Haemorrhage
  4. Oedema
  5. Oedema peripheral
  6. Peripheral swelling
  7. Confusional state
  8. Fluid overload
  9. Fluid retention
  10. Headache

male:

  1. Death
  2. Fluid retention
  3. Nasal congestion
  4. Red blood cell count decreased
  5. Respiratory distress

Common Oxycodone And Acetaminophen and Letairis drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Epistaxis
  2. Fatigue
  3. Haematocrit decreased
  4. Haemoglobin decreased
  5. Nasal congestion
  6. Swelling
  7. Weight decreased
  8. Weight increased

40-49:

n/a

50-59:

  1. Cardiogenic shock
  2. Dyspnoea
  3. Red blood cell count decreased
  4. Terminal state

60+:

  1. Dyspnoea
  2. Nasal congestion
  3. Peripheral swelling
  4. Confusional state
  5. Fluid overload
  6. Fluid retention
  7. Headache
  8. Scoliosis
  9. Pain in extremity
  10. Skin discolouration

Common conditions people have *:

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 17 people, 65.38%
  2. Weight Increased: 2 people, 7.69%
  3. Lung Disorder (lung disease): 2 people, 7.69%
  4. Insomnia (sleeplessness): 2 people, 7.69%
  5. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 7.69%
  6. Cardiac Disorder: 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Oxycodone and acetaminophen and Letairis?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Common Oxycodone and acetaminophen drug interactions:

Browse interactions between Oxycodone and acetaminophen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Letairis drug interactions:

Browse interactions between Letairis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; oxycodone hydrochloride and ambrisentan (the active ingredients of Oxycodone and acetaminophen and Letairis, respectively), and Oxycodone and acetaminophen and Letairis (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Oxycodone and acetaminophen and Letairis.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.